653 Results for "

platelets aggregation

" in MedChemExpress (MCE) Product Catalog:
Products (653)

653 Results for "platelets aggregation" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-19354
CAS No.: 143901-35-3
Synonyms: Aglafolin; Rocaglamide U; (-)-Methyl rocaglate
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

Aglafoline inhibits PAF-induced platelet aggregation, with an IC50 value of 50 μM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101054
CAS No.: 130089-98-4
Purity:  98.98%
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

NQ301 is an antithrombotic agent; inhibits collagen-challenged rabbit platelet aggregation with an IC50 of 10 mg/mL.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-112322
CAS No.: 69552-46-1
Purity:  ≥98.0%
Synonyms: Carbaprostacyclin; Carba-PGI2
Carbacyclin is a PGI2 analogue, acts as a prostacyclin (PGI2) receptor agonist and vasodilator, and potently inhibits platelet aggregation.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N7614
CAS No.: 117210-12-5
Synonyms: Schidigerasaponin F2; Timosaponin AII
Anemarrhenasaponin A2 (Schidigerasaponin F2) is a steroidal saponin isolated from the rhizomes of Anemarrhena asphodeloides. Anemarrhenasaponin A2 inhibits ADP-induced platelet aggregation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-10064S
CAS No.: 1265911-55-4
Ticagrelor-d7 is the deuterium labeled Ticagrelor. Ticagrelor (AZD6140) is a reversible oral P2Y12 receptor antagonist for the treatment of platelet aggregation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-125989
CAS No.: 22140-20-1
Purity:  98.94%
Synonyms: 2-MeSAMP; 2-Methylthioadenosine 5′-monophosphate; 2-Methylthioadenosine 5′-phosphate
Target:  

P2Y Receptor

Research Areas:  

Cardiovascular Disease

2-Methylthio-AMP (2-MeSAMP) is a selective and direct P2Y12 antagonist. 2-Methylthio-AMP is an inhibitor of ADP-dependent platelet aggregation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-114986
CAS No.: 67786-53-2
Purity:  ≥99.0%
Synonyms: 6-keto-Prostaglandin E1
Target:  

β-glucuronidase

Research Areas:  

Cardiovascular Disease

6-Keto-PGE1 (6-keto-Prostaglandin E1) is a biologically active derivative of PGE1. 6-Keto-PGE1 inhibits adenosine diphosphate-induced platelet aggregation. 6-Keto-PGE1 reduces cardiac afterload, decreases the accumulation of plasma myocardial depressant factor (MDF), lowers arterial blood pressure, dilates vascular beds, inhibits the vasoconstrictive response of vascular smooth muscle, and increases pulmonary compliance. 6-Keto-PGE1 directly stabilizes isolated cat liver lysosomes and significantly reduces the release of β-glucuronidase and cathepsin D. 6-Keto-PGE1 prolongs the survival time of traumatized rats and exerts protective effects through hemodynamic and cytoprotective actions. 6-Keto-PGE1 reduces central airway resistance. 6-Keto-PGE1 can be used in studies related to traumatic shock .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-118752
CAS No.: 18046-21-4
Purity:  99.87%
Target:  

COX

Research Areas:  

Inflammation/Immunology

Fentiazac, alkanoic acid derivative, is an orally active non-steroidal anti-inflammatory agent, with analgesic, antipyretic and platelet anti-aggregation activity. Fentiazac can be used to research inflammatory diseases such as rheumatoid arthritis, osteoarthritis and tendinitis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-110052
CAS No.: 934358-00-6
Purity:  99.45%
Target:  

Casein Kinase

Research Areas:  

Cancer

TBCA is a highly selective CK2 (casein kinase II) inhibitor with an IC50 of 110 nM and a Ki of 77 nM. TBCA shows selectivity for CK2 over CK1, DYRK1A and a panel of 27 other kinases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1047
CAS No.: 2037-95-8
Synonyms: Carbonylsalicylamide
Target:  

Drug Intermediate

Research Areas:  

Neurological Disease

Carsalam (Carbonylsalicylamide; 2H-1,3-benzoxazine-2,4-dione) is a salicylamide derivative and precursor compound. Carsalam is a nonsteroidal anti-inflammatory agent and can inhibit platelet aggregation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-A0126A
CAS No.: 61849-14-7
Synonyms: Prostaglandin I2 sodium salt; Prostacyclin sodium salt; Flolan
Epoprostenol sodium (Prostaglandin I2) sodium salt, the synthetic form of the natural prostaglandin derivative prostacyclin (prostaglandin I2), is registered worldwide for the treatment of Pulmonary arterial hypertension (PAH). Epoprostenol sodium is used in pulmonary hypertension and transplantation as a potent inhibitor of platelet aggregation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1263
CAS No.: 327177-34-4
Synonyms: (trans-Cinnamoyl)-YPGKF-NH2
tcY-NH2 ((trans-Cinnamoyl)-YPGKF-NH2) is a potent selective PAR4 antagonist peptide. tcY-NH2 inhibits thrombin- and AY-NH2-induced platelet aggregation and endostatin release, and can be used in the research of inflammation, immunology .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1263A
CAS No.: 1262750-73-1
Synonyms: (trans-Cinnamoyl)-YPGKF-NH2 TFA
tcY-NH2 ((trans-Cinnamoyl)-YPGKF-NH2) TFA is a potent selective PAR4 antagonist peptide. tcY-NH2 TFA inhibits thrombin- and AY-NH2-induced platelet aggregation and endostatin release, and can be used in the research of inflammation, immunology .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0428
CAS No.: 82571-53-7
Synonyms: OKY-046
Ozagrel (OKY-046) is a high selective and orally active thromboxane A2 (TXA2) synthase inhibitor with an IC50 of 11 nM. Ozagrel exerts anti-platelet aggregation, vasodilation and anti-inflammatory effects by inhibiting the production of TXA2 and increasing the production of prostacyclin (PGI2). Ozagrel can be used for the study of ischemic stroke, asthma and thromboembolic diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0428B
CAS No.: 78712-43-3
Synonyms: OKY-046 hydrochloride
Ozagrel hydrochloride (OKY-046 hydrochloride) is a high selective and orally active thromboxane A2 (TXA2) synthase inhibitor with an IC50 of 11 nM. Ozagrel hydrochloride exerts anti-platelet aggregation, vasodilation and anti-inflammatory effects by inhibiting the production of TXA2 and increasing the production of prostacyclin (PGI2). Ozagrel hydrochloride can be used for the study of ischemic stroke, asthma and thromboembolic diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N1887
CAS No.: 1126-61-0
Synonyms: Hydroxychavicol; 4-Allylpyrocatechol
4-Allylcatechol (4-Allylpyrocatechol) is a xylan which has oral activity and can be isolated from the root of Piper taiwanense. 4-Allylcatechol has a strong inhibitory activity against collagen-induced platelet aggregation (IC50 = 5.3 μM). In addition, 4-Allylcatechol has anti-tuberculosis activity against Mycobacterium tuberculosis H37Rv (MIC = 27.6 μg/mL) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101200
CAS No.: 16142-27-1
Purity:  99.97%
Synonyms: SIN-1 chloride
Linsidomine hydrochloride (SIN-1 chloride) is a spontaneous ROS/RNS generator and peroxynitrite donor. Linsidomine hydrochloride is a vasodilator and platelet aggregation inhibitor. Linsidomine hydrochloride induces oxidative stress-induced chondrocyte apoptosis and necrosis. Linsidomine hydrochloride inhibits the migration, proliferation and neointima formation of vascular smooth muscle cells by inhibiting the expression of annexin A2. In addition, low doses of Linsidomine hydrochloride shows protective effects on Zn 2+ treated nerve cells .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-108491
CAS No.: 119567-63-4
Purity:  99.4%
Target:  

SphK Apoptosis

Research Areas:  

Cancer

N,N-Dimethylsphingosine is a sphingosine kinase inhibitor. N,N-Dimethylsphingosine binds competitively to sphingosine kinase and blocks the conversion of sphingosine to sphingosine-1-phosphate. N,N-Dimethylsphingosine inhibits sphingosine-1-phosphate release and aggregation of platelets, and also exerts pro-apoptotic effects by resetting ceramide/sphingosine-1-phosphate homeostasis. N,N-Dimethylsphingosine can be used in cancer-related research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113331
CAS No.: 54397-85-2
Purity:  ≥99.0%
Thromboxane B2 is a prostaglandin derivative that is released during anaphylaxis. Thromboxane B2 induces arterial contraction and platelet aggregation. Thromboxane B2 is a biological inactive product and circulating catabolite of thromboxane A2. Thromboxane B2 levels in peripheral venous blood and coronary sinus blood can be used as a diagnostic marker for angina. Thromboxane B2 level in serum is also associated with inhibition of COX-1 activity inhibition in platelets. Thromboxane B2 is a major product of prostaglandin endoperoxide metabolism. Thromboxane B2 produces dose-related decreases in airflow rate, tidal volume and dynamic lung compliance, whilst simultaneously increasing pulmonary airway resistance in dog model. Thromboxane B2 appears to be a naturally occurring bronchoactive metabolite in the bioconversion of arachidonic acid .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113469
CAS No.: 7665-99-8
Purity:  99.43%
Cyclic GMP (cGMP), an important second messenger, is a major intracellular mediator of extracellular signals such as nitric oxide (NO) and natriuretic peptides (NPs). Effects of Cyclic GMP occur through three main groups of cellular targets: cGMP-dependent protein kinases (PKGs), cGMP-gated cation channels, and PDEs. Cyclic GMP can inhibit both platelet adhesion and aggregation. cGAMP (Cyclic-GMP-AMP) (HY-12512), a conjugate of Cyclic GMP and AMP, can induce IRF3 phosphorylation and nuclear translocation, enhancing antiviral immune responses .
loading...
    loading...